The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-{[2-Acetyl-3-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide ID: ALA1097374
PubChem CID: 46887189
Max Phase: Preclinical
Molecular Formula: C24H28N8O2
Molecular Weight: 460.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cccc1N1CCN(C)CC1
Standard InChI: InChI=1S/C24H28N8O2/c1-14(33)19-17(5-4-6-18(19)32-11-9-30(2)10-12-32)27-24-26-13-15-7-8-16-21(23(25)34)29-31(3)22(16)20(15)28-24/h4-6,13H,7-12H2,1-3H3,(H2,25,34)(H,26,27,28)
Standard InChI Key: AWRGMQGBSTVGKQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
10.9694 -1.9958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9682 -2.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6831 -3.2360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6813 -1.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3966 -1.9922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4000 -2.8206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8283 -1.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1085 -1.5727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8317 -2.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1142 -3.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2882 -4.0419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1133 -4.1270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4491 -3.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1583 -2.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8767 -3.3556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1504 -2.1250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2534 -3.2351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5393 -2.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5404 -1.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8271 -1.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1113 -1.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1133 -2.8254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8272 -3.2347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8708 -4.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8291 -4.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1156 -4.4738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5445 -4.4705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4000 -3.2399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6890 -2.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9778 -3.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9758 -4.0608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6912 -4.4736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4087 -4.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2609 -4.4726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 16 2 0
6 10 1 0
2 17 1 0
9 7 1 0
17 18 1 0
7 8 1 0
18 19 2 0
9 10 2 0
19 20 1 0
5 4 2 0
20 21 2 0
4 1 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 18 1 0
11 24 1 0
2 3 1 0
23 25 1 0
10 11 1 0
25 26 1 0
11 12 1 0
25 27 2 0
12 13 2 0
22 28 1 0
28 29 1 0
13 9 1 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
5 8 1 0
31 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 460.54Molecular Weight (Monoisotopic): 460.2335AlogP: 1.77#Rotatable Bonds: 5Polar Surface Area: 122.27Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.03CX Basic pKa: 6.95CX LogP: 3.16CX LogD: 3.03Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.55Np Likeness Score: -1.05
References 1. Beria I, Ballinari D, Bertrand JA, Borghi D, Bossi RT, Brasca MG, Cappella P, Caruso M, Ceccarelli W, Ciavolella A, Cristiani C, Croci V, De Ponti A, Fachin G, Ferguson RD, Lansen J, Moll JK, Pesenti E, Posteri H, Perego R, Rocchetti M, Storici P, Volpi D, Valsasina B.. (2010) Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors., 53 (9): [PMID:20397705 ] [10.1021/jm901713n ]